https://c2pharma.com/news/acquisition/2018-10-01T12:44:40+02:00https://c2pharma.com/news/cphi-2017-c2-pharma-acquires-rd-synthesis-services-company-and-establishes-cold-chain-logistics-spin-off/2023-05-16T10:50:54+02:00https://c2pharma.com/news/centroflora-cms-changes-its-name-to-c2-pharma/2021-02-23T17:03:45+01:00https://c2pharma.com/news/cep-approval/2023-05-16T11:26:39+02:00https://c2pharma.com/news/cphi-award-nomination/2018-09-26T16:13:39+02:00https://c2pharma.com/news/information-brief/2018-09-25T11:21:54+02:00https://c2pharma.com/news/announcement/2021-01-12T11:30:14+01:00https://c2pharma.com/news/information-brief-2/2018-09-25T11:22:37+02:00https://c2pharma.com/news/winner-of-the-2015-cphi-pharma-award/2021-01-12T11:19:36+01:00https://c2pharma.com/news/major-expansion/2018-09-26T16:16:16+02:00https://c2pharma.com/news/selected-as-a-finalist/2021-01-12T11:22:13+01:00https://c2pharma.com/news/brazilian-pavillion/2018-09-25T11:24:01+02:00https://c2pharma.com/news/award/2021-01-12T10:41:49+01:00https://c2pharma.com/news/chemical-engineering-news/2021-01-12T10:25:49+01:00https://c2pharma.com/news/paris/2022-10-03T11:08:27+02:00https://c2pharma.com/news/c2-pharma-leads/2022-10-03T11:25:45+02:00https://c2pharma.com/news/about-c2-pharma/2022-10-03T11:34:17+02:00https://c2pharma.com/news/financial-times-global-pharmaceutical-and-biotechnology-conference/2021-02-23T15:28:28+01:00https://c2pharma.com/news/c2-pharma-acquires-digoxin-api-portfolio-from-nobilus-ent/2021-02-23T15:26:20+01:00https://c2pharma.com/news/building-resilient-supply-chains-for-niche-apis-how-c%c2%b2-pharma-overcame-the-digoxin-challenge/2019-06-07T10:59:23+02:00https://c2pharma.com/news/why-the-industry-is-forming-bonds-with-cbd/2019-07-01T09:34:44+02:00https://c2pharma.com/news/c2-pharma-continues-to-expand-api-portfolio-with-digoxin-micronized-grade-homatropine-hydrobromide-and-multiple-products-under-tech-transfer-and-development/2023-05-16T10:47:53+02:00https://c2pharma.com/news/c2-pharma-continues-to-expand-api-portfolio/2020-10-02T09:43:11+02:00https://c2pharma.com/news/c2-pharma-leverages-virtual-manufacturing-to-build-secure-supply-chains-a-chemicals-knowledge-featured-story/2021-02-23T15:22:32+01:00https://c2pharma.com/news/fairness-in-the-pharma-supply-chain-key-to-success-in-todays-business-climate/2020-10-02T09:37:17+02:00https://c2pharma.com/news/c2-pharma-highlights-importance-of-api-quality/2020-07-07T15:12:12+02:00https://c2pharma.com/news/andrew-badrot-ceo-of-c2-pharma-weighs-in-on-the-future-trends-of-mergers-and-acquisitions-in-the-life-sciences-industry/2022-10-03T11:38:20+02:00https://c2pharma.com/news/c2-pharma-opens-government-and-research-access-to-safety-stock-of-digoxin-api-for-use-in-potential-covid-19-coronavirus-combination-treatment/2022-10-03T11:42:02+02:00https://c2pharma.com/news/covid-19-coronavirus-is-reshaping-the-pharmaceutical-supply-chain/2022-10-03T11:44:41+02:00https://c2pharma.com/news/lessons-from-a-modern-day-pandemic-redesigning-the-pharmaceutical-supply-chain-a-manufacturing-chemist-featured-story/2022-10-03T11:47:34+02:00https://c2pharma.com/news/andrew-badrot-ceo-of-c2-pharma-speaks-on-how-the-pharma-industry-has-responded-to-the-covid-19-pandemic-a-pharmas-almanac-q2-issue/2022-10-03T11:49:05+02:00https://c2pharma.com/news/andrew-badrot-ceo-of-c2-pharma-speaks-on-developing-technologies-that-will-have-the-greatest-impact-on-the-biopharma-industry-in-2020-and-beyond-a-pharmas-almanac-q4-issue/2021-02-23T16:25:10+01:00https://c2pharma.com/news/connecting-industry-across-the-globe-a-chemicals-knowledge-featured-story/2022-10-03T11:53:38+02:00https://c2pharma.com/news/the-impact-of-covid-19-on-the-pharmaceutical-industry/2022-10-03T11:56:21+02:00https://c2pharma.com/news/c2-pharma-finalist-in-excellence-in-pharma-sustainability-the-cphi-pharma-awards-2020/2022-10-03T12:00:09+02:00https://c2pharma.com/news/interview-with-andrew-badrot-c2-pharma-ceo-a-letzebuerger-merkur-featured-story/2023-05-16T10:43:47+02:00https://c2pharma.com/news/andrew-badrot-c2-pharma-ceo-speaks-on-working-to-mitigate-risks-for-future-crises-like-the-covid-19-pandemic/2022-10-03T12:04:56+02:00https://c2pharma.com/news/c2-pharma-completes-multiple-regulatory-filings-expands-portfolio/2023-05-16T10:43:21+02:00https://c2pharma.com/news/pharmaceutical-reshoring-a-healthy-requirement-a-strategic-necessity-a-manufacturing-chemist-featured-story/2022-10-03T12:11:27+02:00https://c2pharma.com/news/c2-pharma-at-cphi-2021-in-milan/2022-10-03T12:12:52+02:00https://c2pharma.com/news/c2-pharma-completes-multiple-local-regulatory-filings-and-expands-portfolio/2023-05-16T10:39:35+02:00https://c2pharma.com/news/c2-pharma-at-cphi-2022-in-frankfurt/2022-10-03T12:39:07+02:00https://c2pharma.com/news/what-goes-wrong-when-api-quality-is-compromised/2022-10-03T12:37:36+02:00https://c2pharma.com/news/c2-pharma-expands-ophthalmic-api-portfolio-with-tropicamide-launch-multiple-regulatory-filings/2023-05-16T10:36:37+02:00https://c2pharma.com/news/sarah-breen-senior-quality-manager-at-c2-pharma-shares-her-thoughts-on-supplier-oversight-with-susan-haigney-from-pharmaceutical-technology/2022-11-21T09:34:58+01:00https://c2pharma.com/news/andrew-badrot-c2-pharma-ceo-is-interviewed-by-mjh-life-sciences-during-cphi-2022-in-frankfurt-and-discusses-the-future-of-the-company-and-the-cmo-industry-in-general/2023-05-16T10:27:32+02:00https://c2pharma.com/news/check-out-what-we-have-to-offer-as-your-api-manufacturing-partner/2023-05-16T10:29:28+02:00https://c2pharma.com/news/ceo-deep-dive-with-cleanroom-technology/2023-03-17T16:03:53+01:00https://c2pharma.com/news/assuring-security-of-supply-for-phyto-apis/2023-03-17T16:49:57+01:00https://c2pharma.com/news/c2-pharma-receives-approval-for-digoxin-china-dmf-becoming-chinas-only-european-supplier-of-this-api/2023-06-27T14:20:41+02:00https://c2pharma.com/news/celebrating-a-milestone-cyclopentolate-cep-approval/2023-07-06T08:31:19+02:00https://c2pharma.com/news/edqm-grants-c2-pharma-cep-approval-for-commercial-sale-of-cyclopentolate-hydrochloride/2023-06-27T14:24:39+02:00https://c2pharma.com/news/head-of-quality-tara-fitzpatrick-interviews-with-pharma-techs-felicity-thomas/2023-10-02T13:45:50+02:00https://c2pharma.com/news/c2-pharma-expands-api-portfolio-with-global-regulatory-access-ahead-of-cphi-barcelona/2023-10-17T14:22:26+02:00https://c2pharma.com/news/senior-manager-business-development-serge-tarabay-pharmasource-podcast-interview/2023-10-18T12:12:17+02:00https://c2pharma.com/news/optimizing-the-total-cost-of-ownership-by-c2-pharmas-ceo-andrew-badrot/2023-10-30T10:23:59+01:00https://c2pharma.com/news/manufacturing-chemist-interview-with-c2-pharmas-ceo-at-cphi-ww-barcelona/2023-11-07T16:18:43+01:00https://c2pharma.com/news/c2-pharma-receives-dmf-approval-in-china-for-pilocarpine-nitrate/2023-11-22T10:58:55+01:00https://c2pharma.com/news/c2-pharma-x-pharmasource-ophthalmics-buyer-guide/2024-02-15T09:13:37+01:00https://c2pharma.com/news/c2-pharmas-upcoming-launch-of-oxybuprocaine-hydrochloride/2024-03-06T15:21:53+01:00https://c2pharma.com/news/c2-pharma-receives-cep-approval-for-tropicamide/2024-07-30T11:04:41+02:00https://c2pharma.com/news/c2-pharma-expands-ophthalmic-api-portfolio-with-naphazoline-hydrochloride-launch/2024-09-12T09:07:57+02:00https://c2pharma.com/news/c2-pharma-marks-10th-year-anniversary-attendance-at-cphi-milan-with-expanded-ophthalmic-api-portfolio/2024-09-24T09:55:49+02:00https://c2pharma.com/news/c2-pharma-receives-cep-approval-for-oxybuprocaine-hydrochloride/2025-09-16T10:52:19+02:00https://c2pharma.com/news/c2-pharma-receives-cep-approval-for-latanoprost/2025-09-17T13:02:08+02:00https://c2pharma.com/news/c2-pharma-strengthens-ophthalmic-api-portfolio-with-timolol-maleate-launch/2025-10-13T12:59:05+02:00https://c2pharma.com/news/c2-pharma-receives-c-dmf-approval-for-brimonidine-tartrate/2026-03-05T11:16:59+01:00https://c2pharma.com/news/c2-pharma-expands-ophthalmic-api-portfolio-with-the-launch-of-dorzolamide-hydrochloride/2026-03-11T16:43:15+01:00https://c2pharma.com/news/c2-pharma-receives-cep-approval-for-naphazoline-hydrochloride/2026-04-22T16:45:35+02:00https://c2pharma.com/news/c2-pharma-receives-cep-approval-for-naphazoline-nitrate/2026-04-23T15:13:00+02:00